Journal of Biomedicines & Biomarkers is a peer-reviewed, open access journal that publishes high quality and innovative research and reviews related to biomarker and biomedical investigation. The journal is currently accepting original discoveries, in-depth reviews, novel concepts, short commentaries, review papers, editorials, perspective articles, conference proceedings, case studies etc.
Journal of Biomedicines & Biomarkers is publishing high quality papers that address the challenges in bringing validation/identification of biomarkers in drug development or drug discovery, disease diagnosis, treatment, prognosis and prevention. It also publishes novel concepts about biological agents or novel targeted strategies through identification, development and its application in clinical use. Thus, all types of basic research, comprehensive preclinical studies, clinical investigations and clinical trials are all within the scope of the journal.
Preliminary Quality Check/Plagiarism Report: Within 3 days of Submission
Peer Review Process Time: Within 2-4 weeks
Report on Revised Manuscripts: Within 1-2 weeks
Galley Proof to Authors: Within 3 days after Acceptance
Approve Galley Proof Moved to Article in Press: Immediately after Approval of Galley Proof
Archiving: Journal of Biomedicines & Biomarkers is published by Edwiser International which is permanently archived in PORTICO. Thus, it helps is safe guard the scientific content for future generations.
Flexibility: Online publication with Journal of Biomedicines & Biomarkers gives authors the flexibility to publish large datasets, large numbers of colour illustrations for better understanding of the concept.
Copyright: The authors of an article published in Journal of Biomedicines & Biomarkers retains the copyright their article and they are free to reproduce and disseminate their work.
Cost-effective: We do not charge thousands of dollars as a part of publication fee. Publication in Journal of Biomedicines & Biomarkers charges only nominal fee to cover up the publication cost. For details check author guidelines
Transparency: The complete peer review process is kept transparent to fetch out the best possible result.
Discounts: Multiple submissions is provided with huge discounts which further lessen up the burden of publication cost.
Trustworthiness: Researchers from top notch universities trust are platform.
All works published by Edwiser International are under the terms of the creative commons attribution 4.0 international license. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Biomedicines & Biomarkers supports the Open Access initiative. We believe in giving the maximum exposure to our published articles, so that the author could get the highest impact for his publications. For publication ethics visit here.
Journal of Biomedicines & Biomarkers is a broad-spectrum journal covering all the topics of biomedical and biomarker research. The journal publishes high quality papers in the below mentioned topics but are not limited to it: